The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
3 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,729,209 in first-year total cost, median $612,989.
Most frequent study sections
- Cancer, Heart, and Sleep Epidemiology A Study Section[CHSA]1
- Clinical and Integrative Cardiovascular Sciences Study Section[CICS]1
- Special Emphasis Panel[ZRG1 NRCS-V (08)]1
Most frequent institutions
- KAISER FOUNDATION RESEARCH INSTITUTE1
- VANDERBILT UNIVERSITY MEDICAL CENTER1
- WAKE FOREST UNIVERSITY HEALTH SCIENCES1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2018 | Novel mechanisms and predictors of VEGF receptor inhibitor-associated hypertension1R56HL141466-01 | MOSLEHI, JAVID J | VANDERBILT UNIVERSITY MEDICAL CENTER, TN | $612,989 | CICS |
| 2018 | Assessing efficacy and implementation of an EHR tool to assess heart health among survivors1R01CA226078-01 | FORAKER, RANDI EWEAVER, KATHRYN ELIZABETH | WAKE FOREST UNIVERSITY HEALTH SCIENCES, NC | $499,843 | ZRG1 |
| 2017 | Predictors of CVD among breast cancer survivors in an integrated health system1R01CA214057-01A1 | GREENLEE, HEATHERKWAN, MARILYN L | KAISER FOUNDATION RESEARCH INSTITUTE, CA | $616,377 | CHSA |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.